Replay - Crunchbase Company Profile & Funding

Q: Where is Replay's headquarters?

Replay is located in San Diego, California, United States.

Q: Who invested in Replay?

Replay has 7 investors including OMX Ventures And Kohlberg Kravis Roberts & Co..

Q: When was the last funding round for Replay?

Replay closed its last funding round on obfuscated from a Series A round.

Overview

Replay

Total Funding

obfuscation

Growth Score

Heat Score

Company Performance Metrics

Score

Trend

About These Metrics

AI Content may contain mistakes and is not legal, financial or investment advice.

Learn more.

Growth Score - The measure of growth based on company activity, operational metrics, and investments

Growth Trend - The change in the growth score over the given time period

Heat Score - The measure of the market interest, media activity, and Crunchbase profile activity

Heat Trend - The change in the heat score over the given time period

Recent Milestones

Raised Funding Round

Jan 1, 1970

Lorem ipsum dolor sit amet, consectetur

Raised Funding Round

Jan 1, 1970

Lorem ipsum dolor sit amet, consectetur

Raised Funding Round

Jan 1, 1970

Lorem ipsum dolor sit amet, consectetur

See more interactive data and historical milestones on desktop for the best experience

About Replay

CB Rank

5328

Replay is a genome writing company reprogramming biology by writing and delivering big DNA.

Acquired by

LEO Pharma

Founded

obfuscation

Private

Series A

San Diego, California, United States

11-50

replay.bio/

Biotechnology

Therapeutics

Funding Rounds

Series A

OBF

obfuscation

Seed

OBF

obfuscation

Key People

Lachlan MacKinnon: CEO & Founder

Details

Legal Name

Replay Holdings LLC

Operating Status

Active

Company Type

For Profit

Founders

Adrian Woolfson, Lachlan MacKinnon

About the Company

Replay is a genome writing company, which aims to define the future of genomic medicine through reprogramming biology by writing and delivering big DNA.

Contact Email

info@replay.bio

Predictions & Insights

Growth Prediction

See this Growth Prediction

Top Contributing Factors

Key Employee Changes

Products & Services

synHSV™ High Payload Capacity HSV Vector

A herpes simplex virus (HSV) vector capable of delivering large DNA payloads, up to 30 times the size of adeno-associated virus (AAV) vectors, for gene therapy applications.

Eudora Gene Therapy Product Company

A gene therapy company using synHSV™ technology to develop treatments for genetic retinal diseases such as retinitis pigmentosa, Stargardt disease, and Usher syndrome type 1B.

Unlock More with Crunchbase Pro

Full access to financial & funding data on unlimited profiles
Export up to 2k results/month for analysis
Track market signals on competitors, products, and R&D
Preview private company insights and predictions

Financials

Company Funding

Funding Rounds

Investors

Total Funding Amount

obfuscation

Number of Funding Rounds

Unlock company funding data, including rounds, dates, amounts, and investors.

Announced Date	Transaction Name	Number of Investors	Money Raised	Lead Investors	Funding Type
obfuscated obfuscation	Series A - Replay	7	obfuscated obfuscation	Kohlberg Kravis Roberts & Co., OMX Ventures	Series A
obfuscated obfuscation	Series A - Replay	7	obfuscated obfuscation	Kohlberg Kravis Roberts & Co., OMX Ventures	Series A
obfuscated obfuscation	Series A - Replay	7	obfuscated obfuscation	Kohlberg Kravis Roberts & Co., OMX Ventures	Series A
obfuscated obfuscation	Series A - Replay	7	obfuscated obfuscation	Kohlberg Kravis Roberts & Co., OMX Ventures	Series A
obfuscated obfuscation	Series A - Replay	7	obfuscated obfuscation	Kohlberg Kravis Roberts & Co., OMX Ventures	Series A

Funding Rounds

Total Funding Amount

obfuscation

Number of Funding Rounds

Unlock company funding data, including rounds, dates, amounts, and investors.

Announced Date	Transaction Name	Number of Investors	Money Raised	Lead Investors	Funding Type
obfuscated obfuscation	Series A - Replay	7	obfuscated obfuscation	Kohlberg Kravis Roberts & Co., OMX Ventures	Series A
obfuscated obfuscation	Series A - Replay	7	obfuscated obfuscation	Kohlberg Kravis Roberts & Co., OMX Ventures	Series A
obfuscated obfuscation	Series A - Replay	7	obfuscated obfuscation	Kohlberg Kravis Roberts & Co., OMX Ventures	Series A
obfuscated obfuscation	Series A - Replay	7	obfuscated obfuscation	Kohlberg Kravis Roberts & Co., OMX Ventures	Series A
obfuscated obfuscation	Series A - Replay	7	obfuscated obfuscation	Kohlberg Kravis Roberts & Co., OMX Ventures	Series A

Investors

Unlock company funding data, including rounds, dates, amounts, and investors.

Investor Name	Lead Investor	Funding Round	Partners
OMX Ventures	Yes	Series A - Replay	Nick Haft
OMX Ventures	Yes	Series A - Replay	Nick Haft
OMX Ventures	Yes	Series A - Replay	Nick Haft
OMX Ventures	Yes	Series A - Replay	Nick Haft
OMX Ventures	Yes	Series A - Replay	Nick Haft